The Case for Greater Investment in VTE Research – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Ryan Coute et al, adding:
“National Institutes of Health Funding for Venous Thromboembolism Research.
Despite VTE causing approximately 100,000 annual US deaths, NIH funding per death remains critically disproportionate at 639 dollars for VTE compared to 2,765 dollars for heart disease and 2,724 dollars for stroke, highlighting a significant research investment gap that urgently needs to be addressed.”
Title: National Institutes of Health funding for venous thromboembolism research
Authors: Ryan A. Coute, Jake Toy, Kameshwari Soundararajan, Benjamin von Schweinitz, Patrick J. Siler, Ryan C. Godwin, Ryan L. Melvin
Read the Full Article on Journal of Thrombosis and Haemostasis.
Stay updated on all scientific advances with Hemostasis Today.
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress
-
May 5, 2026, 16:17Hannah Omunakwe: Your Sick Child Has a Clot. Did You See That Coming?
-
May 5, 2026, 15:57Venous Thromboembolism Risk in Pregnancy and the Postpartum Period – NBCA
-
May 5, 2026, 15:28Soumen Bhattacharyya: Hyperhomocysteinemia and Thrombosis – What Clinicians Should Know
-
May 5, 2026, 15:06Wolfgang Miesbach: How Should We Approach GI Angiodysplasia in VWD?
-
May 5, 2026, 14:48What Constitutes High Risk for Venous Thromboembolism? – JTH
-
May 5, 2026, 14:41How Real-Time Data, Rehabilitation Registries, and Patient-Reported Outcomes Can Transform Practice – European Stroke Organisation
-
May 5, 2026, 14:41Driving National Change for Bleeding Disorders – WFH